Strides Pharma Science is currently trading at Rs. 368.05, up by 23.60 points or 6.85% from its previous closing of Rs. 344.45 on the BSE.
The scrip opened at Rs. 346.00 and has touched a high and low of Rs. 377.70 and Rs. 344.00 respectively. So far 233704 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 10 has touched a 52 week high of Rs. 550.40 on 22-Jan-2019 and a 52 week low of Rs. 288.00 on 09-Oct-2019.
Last one week high and low of the scrip stood at Rs. 377.70 and Rs. 336.35 respectively. The current market cap of the company is Rs. 3249.30 crore.
The promoters holding in the company stood at 31.28%, while Institutions and Non-Institutions held 46.45% and 22.27% respectively.
Strides Pharma Science has reported net profit of Rs 47 crore for the quarter ended September 30, 2019 as against net loss of Rs 14.30 crore for the same quarter in the previous year. Total income of the company increased by 27.54% at Rs 457.61 crore for Q2FY20 as compared Rs 358.79 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported net profit of Rs 141.91 crore for the quarter under review as against net loss of Rs 8.70 crore for the same quarter in the previous year. Total income of the company increased by 37.51% at Rs 728.08 crore for Q2FY20 as compared Rs 529.46 crore for the corresponding quarter previous year.